OLMA · Olema Pharmaceuticals Inc. Common Stock
View on chartInsiders & Stakes
| Bain Capital Life Sciences Investors, LLC 10% Owner | ▼ Sell | Other | 4,300,000 Shares held | 1/10/2025 | View profile |
| Graham G. Walmsley Director | ▲ Buy | Open Market | 1,408,875 Shares held | 12/17/2024 | View profile |
| Paradigm Biocapital Advisors LP 10% Owner | ▼ Sell | Open Market | 783,118 Shares held | 8/1/2024 | View profile |
| Cyrus Harmon CHIEF TECHNOLOGY OFFICER | ▼ Sell | Open Market | 702,770 Shares held | 7/24/2026 | View profile |
| David C. Myles CHIEF DEVELOPMENT OFFICER | ▼ Sell | Open Market | 542,761 Shares held | 1/14/2026 | View profile |
| BVF PARTNERS L P/IL 10% Owner | ▼ Sell | Other | 347,970 Shares held | 1/10/2025 | View profile |
| Sean Bohen PRESIDENT AND CEO | ▼ Sell | Gift | 237,650 Shares held | 12/26/2025 | View profile |
| Shane William Charles Kovacs CH. OPERATING & FINANCIAL OFF. | ▼ Sell | Open Market | 139,727 Shares held | 1/15/2026 | View profile |
| Sasha Lu Austin VP of Finance and Controller | ▲ Buy | Grant | 16,188 Shares held | 2/2/2026 | View profile |
| Naseem Zojwalla CHIEF MEDICAL OFFICER | ▼ Sell | Open Market | 4,488 Shares held | 12/23/2025 | View profile |
| Kinney Horn CHIEF BUSINESS OFFICER | ▼ Sell | Open Market | 2,458 Shares held | 3/10/2022 | View profile |
| Ian T. Clark Director | ▼ Sell | Open Market | 0 Shares held | 12/19/2025 | View profile |
| Shawnte Mitchell CHIEF LEGAL OFFICER | ▼ Sell | Open Market | 0 Shares held | 3/4/2026 | View profile |
| Andrew Rappaport | ▼ Sell | Gift | 0 Shares held | 11/25/2025 | View profile |
Transaction History
| Cyrus Harmon | ▼ Sell | Open Market | 12,500 | $146K | 7/24/2026 |
| Cyrus Harmon | ▼ Sell | Open Market | 12,500 | $145K | 7/23/2026 |
| Shawnte Mitchell | ▲ Buy | Option Exercise | 25,000 | $109K | 3/4/2026 |
| Shawnte Mitchell | ▼ Sell | Open Market | 24,767 | $601K | 3/4/2026 |
| Shawnte Mitchell | ▼ Sell | Open Market | 233 | $6K | 3/4/2026 |
| Shawnte Mitchell | ▲ Buy | Option Exercise | 15,000 | $66K | 3/3/2026 |
| Shawnte Mitchell | ▼ Sell | Open Market | 15,000 | $345K | 3/3/2026 |
| Sasha Lu Austin | ▲ Buy | Grant | 11,700 | $0 | 2/2/2026 |
| Cyrus Harmon | ▼ Sell | Open Market | 10,000 | $269K | 1/20/2026 |
| Shane William Charles Kovacs | ▼ Sell | Open Market | 100,000 | $2.9M | 1/15/2026 |
| Cyrus Harmon | ▼ Sell | Open Market | 3,489 | $102K | 1/14/2026 |
| David C. Myles | ▲ Buy | Option Exercise | 50,000 | $244K | 1/14/2026 |
| David C. Myles | ▼ Sell | Open Market | 14,997 | $429K | 1/14/2026 |
| David C. Myles | ▼ Sell | Open Market | 35,003 | $1.0M | 1/14/2026 |
| Shane William Charles Kovacs | ▼ Sell | Open Market | 3,822 | $107K | 1/13/2026 |
| David C. Myles | ▲ Buy | Option Exercise | 50,000 | $244K | 1/13/2026 |
| David C. Myles | ▼ Sell | Open Market | 49,800 | $1.4M | 1/13/2026 |
| David C. Myles | ▼ Sell | Open Market | 200 | $6K | 1/13/2026 |
| David C. Myles | ▼ Sell | Open Market | 10,000 | $283K | 1/12/2026 |
| Sean Bohen | ▼ Sell | Gift | 8,500 | $0 | 12/26/2025 |
| Naseem Zojwalla | ▲ Buy | Option Exercise | 50,000 | $351K | 12/23/2025 |
| Naseem Zojwalla | ▼ Sell | Open Market | 99,509 | $2.8M | 12/23/2025 |
| Naseem Zojwalla | ▲ Buy | Option Exercise | 7,182 | $50K | 12/22/2025 |
| Naseem Zojwalla | ▲ Buy | Option Exercise | 42,818 | $653K | 12/22/2025 |
| Naseem Zojwalla | ▼ Sell | Open Market | 100,000 | $2.8M | 12/22/2025 |
| Cyrus Harmon | ▼ Sell | Open Market | 2,881 | $82K | 12/22/2025 |
| Ian T. Clark | ▼ Sell | Open Market | 41,840 | $1.3M | 12/19/2025 |
| David C. Myles | ▼ Sell | Open Market | 1,225 | $34K | 12/19/2025 |
| David C. Myles | ▼ Sell | Open Market | 43,729 | $1.3M | 12/19/2025 |
| David C. Myles | ▼ Sell | Open Market | 6,046 | $190K | 12/19/2025 |
| David C. Myles | ▼ Sell | Gift | 9,000 | $0 | 12/19/2025 |
| Naseem Zojwalla | ▲ Buy | Option Exercise | 40,000 | $610K | 12/19/2025 |
| Naseem Zojwalla | ▼ Sell | Open Market | 57,079 | $1.6M | 12/19/2025 |
| Naseem Zojwalla | ▼ Sell | Open Market | 12,921 | $374K | 12/19/2025 |
| Ian T. Clark | ▼ Sell | Open Market | 193,056 | $5.7M | 12/19/2025 |
| Ian T. Clark | ▲ Buy | Option Exercise | 209,690 | $924K | 12/19/2025 |
| Ian T. Clark | ▲ Buy | Option Exercise | 21,520 | $78K | 12/19/2025 |
| Ian T. Clark | ▲ Buy | Option Exercise | 21,520 | $169K | 12/19/2025 |
| Ian T. Clark | ▲ Buy | Option Exercise | 12,070 | $49K | 12/19/2025 |
| Ian T. Clark | ▼ Sell | Open Market | 29,904 | $862K | 12/19/2025 |
| Shane William Charles Kovacs | ▼ Sell | Gift | 75,000 | $0 | 12/8/2025 |
| Shane William Charles Kovacs | ▼ Sell | Gift | 225,000 | $0 | 11/26/2025 |
| Andrew Rappaport | ▼ Sell | Gift | 35,868 | $0 | 11/25/2025 |
| Andrew Rappaport | ▲ Buy | Option Exercise | 35,868 | $14K | 11/21/2025 |
| Cyrus Harmon | ▼ Sell | Open Market | 3,086 | $26K | 9/18/2025 |
| Cyrus Harmon | ▼ Sell | Open Market | 10,000 | $83K | 9/18/2025 |
| Cyrus Harmon | ▼ Sell | Open Market | 10,000 | $80K | 9/16/2025 |
| Cyrus Harmon | ▼ Sell | Open Market | 1,914 | $15K | 9/16/2025 |
| BVF PARTNERS L P/IL | ▼ Sell | Other | 235,450 | — | 1/10/2025 |
| Bain Capital Life Sciences Investors, LLC | ▼ Sell | Other | 3,500,000 | — | 1/10/2025 |
| BVF PARTNERS L P/IL | ▼ Sell | Other | 22,740 | — | 1/10/2025 |
| BVF PARTNERS L P/IL | ▼ Sell | Other | 161,810 | — | 1/10/2025 |
| Bain Capital Life Sciences Investors, LLC | ▲ Buy | Open Market | 300,000 | $1.7M | 1/8/2025 |
| Graham G. Walmsley | ▼ Sell | Open Market | 700,761 | $4.7M | 12/17/2024 |
| Graham G. Walmsley | ▲ Buy | Open Market | 700,761 | $4.7M | 12/17/2024 |
| Naseem Zojwalla | ▲ Buy | Option Exercise | 14,000 | $68K | 12/16/2024 |
| Cyrus Harmon | ▼ Sell | Open Market | 7,958 | $69K | 12/11/2024 |
| Cyrus Harmon | ▼ Sell | Open Market | 179 | $2K | 12/11/2024 |
| David C. Myles | ▼ Sell | Open Market | 13,314 | $115K | 12/11/2024 |
| David C. Myles | ▼ Sell | Open Market | 300 | $3K | 12/11/2024 |
| Naseem Zojwalla | ▼ Sell | Open Market | 14,202 | $123K | 12/11/2024 |
| Naseem Zojwalla | ▼ Sell | Open Market | 320 | $3K | 12/11/2024 |
| Shane William Charles Kovacs | ▼ Sell | Open Market | 17,950 | $155K | 12/11/2024 |
| Shane William Charles Kovacs | ▼ Sell | Open Market | 406 | $4K | 12/11/2024 |
| Sean Bohen | ▼ Sell | Open Market | 55,907 | $484K | 12/11/2024 |
| Sean Bohen | ▼ Sell | Open Market | 1,267 | $12K | 12/11/2024 |
| Cyrus Harmon | ▼ Sell | Open Market | 8,256 | $77K | 12/10/2024 |
| David C. Myles | ▼ Sell | Open Market | 12,452 | $117K | 12/10/2024 |
| Naseem Zojwalla | ▼ Sell | Open Market | 13,283 | $124K | 12/10/2024 |
| Shane William Charles Kovacs | ▼ Sell | Open Market | 16,803 | $157K | 12/10/2024 |
| Sean Bohen | ▼ Sell | Open Market | 52,328 | $490K | 12/10/2024 |
| Cyrus Harmon | ▲ Buy | Grant | 29,250 | $0 | 12/9/2024 |
| David C. Myles | ▲ Buy | Grant | 48,750 | $0 | 12/9/2024 |
| Naseem Zojwalla | ▲ Buy | Grant | 52,000 | $0 | 12/9/2024 |
| Shane William Charles Kovacs | ▲ Buy | Grant | 68,250 | $0 | 12/9/2024 |
| Sean Bohen | ▲ Buy | Grant | 204,750 | $0 | 12/9/2024 |
| BVF PARTNERS L P/IL | ▼ Sell | Other | 1,797,527 | — | 12/4/2024 |
| BVF PARTNERS L P/IL | ▼ Sell | Other | 1,418,736 | — | 12/4/2024 |
| BVF PARTNERS L P/IL | ▼ Sell | Other | 153,441 | — | 12/4/2024 |
| Shane William Charles Kovacs | ▲ Buy | Option Exercise | 25,000 | $176K | 11/15/2024 |
| Paradigm Biocapital Advisors LP | ▼ Sell | Open Market | 1,870,499 | $27.9M | 8/1/2024 |
| Paradigm Biocapital Advisors LP | ▼ Sell | Open Market | 529,501 | $7.9M | 8/1/2024 |
| Cyrus Harmon | ▼ Sell | Open Market | 934 | $15K | 7/30/2024 |
| Cyrus Harmon | ▼ Sell | Open Market | 4,066 | $63K | 7/29/2024 |
| Cyrus Harmon | ▼ Sell | Open Market | 5,000 | $61K | 7/11/2024 |
| Cyrus Harmon | ▼ Sell | Open Market | 20,000 | $215K | 6/28/2024 |
| Graham G. Walmsley | ▼ Sell | Open Market | 700,000 | $10.4M | 6/4/2024 |
| Graham G. Walmsley | ▼ Sell | Open Market | 475,000 | $7.1M | 6/4/2024 |
| Cyrus Harmon | ▼ Sell | Open Market | 5,000 | $62K | 6/4/2024 |
| Cyrus Harmon | ▼ Sell | Open Market | 5,000 | $55K | 6/3/2024 |
| Cyrus Harmon | ▼ Sell | Open Market | 15,000 | $141K | 5/31/2024 |
| Naseem Zojwalla | ▲ Buy | Option Exercise | 9,460 | $46K | 5/24/2024 |
| Cyrus Harmon | ▼ Sell | Open Market | 5,000 | $55K | 5/6/2024 |
| Cyrus Harmon | ▼ Sell | Open Market | 15,000 | $143K | 4/30/2024 |
| Cyrus Harmon | ▼ Sell | Open Market | 20,000 | $219K | 3/28/2024 |
| Naseem Zojwalla | ▲ Buy | Option Exercise | 13,700 | $67K | 3/18/2024 |
| Andrew Rappaport | ▼ Sell | Other | 481,014 | $0 | 3/5/2024 |
| Andrew Rappaport | ▼ Sell | Other | 385,965 | $0 | 3/5/2024 |
| Cyrus Harmon | ▼ Sell | Open Market | 24,900 | $309K | 2/29/2024 |
| Cyrus Harmon | ▼ Sell | Open Market | 100 | $1K | 2/29/2024 |
| Cyrus Harmon | ▼ Sell | Open Market | 5,000 | $78K | 2/1/2024 |
| Cyrus Harmon | ▼ Sell | Open Market | 25,000 | $306K | 1/31/2024 |
| Naseem Zojwalla | ▲ Buy | Option Exercise | 20,000 | $140K | 1/25/2024 |
| Shane William Charles Kovacs | ▲ Buy | Option Exercise | 50,000 | $351K | 1/12/2024 |
| Cyrus Harmon | ▼ Sell | Open Market | 22,500 | $299K | 12/29/2023 |
| Cyrus Harmon | ▼ Sell | Open Market | 2,500 | $35K | 12/29/2023 |
| Shane William Charles Kovacs | ▲ Buy | Option Exercise | 10,000 | $70K | 12/12/2023 |
| Naseem Zojwalla | ▲ Buy | Option Exercise | 2,900 | $20K | 12/11/2023 |
| Naseem Zojwalla | ▲ Buy | Option Exercise | 13,100 | $92K | 12/6/2023 |
| Paradigm Biocapital Advisors LP | ▲ Buy | Open Market | 100,000 | $1.2M | 12/6/2023 |
| Graham G. Walmsley | ▲ Buy | Open Market | 31,870 | $470K | 12/5/2023 |
| Graham G. Walmsley | ▲ Buy | Open Market | 50,000 | $747K | 12/5/2023 |
| Graham G. Walmsley | ▲ Buy | Open Market | 50,000 | $654K | 12/5/2023 |
| Cyrus Harmon | ▼ Sell | Open Market | 25,000 | $314K | 11/30/2023 |
| Cyrus Harmon | ▼ Sell | Open Market | 3,989 | $55K | 11/22/2023 |
| Naseem Zojwalla | ▼ Sell | Open Market | 7,095 | $99K | 11/22/2023 |
| David C. Myles | ▼ Sell | Open Market | 6,653 | $92K | 11/22/2023 |
| Sean Bohen | ▼ Sell | Open Market | 27,932 | $388K | 11/22/2023 |
| Shane William Charles Kovacs | ▼ Sell | Open Market | 9,145 | $127K | 11/22/2023 |
| Cyrus Harmon | ▼ Sell | Open Market | 4,192 | $62K | 11/21/2023 |
| Naseem Zojwalla | ▼ Sell | Open Market | 7,261 | $108K | 11/21/2023 |
| Naseem Zojwalla | ▼ Sell | Open Market | 200 | $3K | 11/21/2023 |
| David C. Myles | ▼ Sell | Open Market | 6,776 | $101K | 11/21/2023 |
| David C. Myles | ▼ Sell | Open Market | 200 | $3K | 11/21/2023 |
| Sean Bohen | ▼ Sell | Open Market | 26,691 | $396K | 11/21/2023 |
| Sean Bohen | ▼ Sell | Open Market | 2,602 | $40K | 11/21/2023 |
| Shane William Charles Kovacs | ▼ Sell | Open Market | 8,897 | $132K | 11/21/2023 |
| Shane William Charles Kovacs | ▼ Sell | Open Market | 700 | $11K | 11/21/2023 |
| Cyrus Harmon | ▲ Buy | Grant | 15,750 | $0 | 11/20/2023 |
| Naseem Zojwalla | ▲ Buy | Grant | 28,000 | $0 | 11/20/2023 |
| David C. Myles | ▲ Buy | Grant | 26,250 | $0 | 11/20/2023 |
| Sean Bohen | ▲ Buy | Grant | 110,250 | $0 | 11/20/2023 |
| Shane William Charles Kovacs | ▲ Buy | Grant | 36,750 | $0 | 11/20/2023 |
| David C. Myles | ▼ Sell | Open Market | 200 | $4K | 11/8/2023 |
| David C. Myles | ▼ Sell | Open Market | 541 | $9K | 11/3/2023 |
| David C. Myles | ▼ Sell | Open Market | 3,332 | $51K | 11/2/2023 |
| Cyrus Harmon | ▼ Sell | Open Market | 5,000 | $78K | 11/2/2023 |
| David C. Myles | ▼ Sell | Open Market | 6,668 | $100K | 11/1/2023 |
| Cyrus Harmon | ▼ Sell | Open Market | 25,000 | $301K | 10/31/2023 |
| Cyrus Harmon | ▼ Sell | Open Market | 25,000 | $310K | 9/29/2023 |
| David C. Myles | ▼ Sell | Open Market | 20,000 | $253K | 9/19/2023 |
| BVF PARTNERS L P/IL | ▼ Sell | Other | 99,556 | — | 9/14/2023 |
| Graham G. Walmsley | ▲ Buy | Open Market | 508,130 | $5.0M | 9/12/2023 |
| BVF PARTNERS L P/IL | ▲ Buy | Open Market | 775,278 | $7.6M | 9/12/2023 |
| BVF PARTNERS L P/IL | ▲ Buy | Open Market | 677,853 | $6.7M | 9/12/2023 |
| BVF PARTNERS L P/IL | ▲ Buy | Open Market | 52,801 | $520K | 9/12/2023 |
| Cyrus Harmon | ▼ Sell | Open Market | 10,000 | $116K | 9/5/2023 |
| Cyrus Harmon | ▼ Sell | Open Market | 15,000 | $140K | 8/31/2023 |
| Cyrus Harmon | ▼ Sell | Open Market | 15,000 | $152K | 8/16/2023 |
| Cyrus Harmon | ▼ Sell | Open Market | 10,000 | $63K | 6/8/2023 |
| Cyrus Harmon | ▼ Sell | Open Market | 5,000 | $31K | 6/6/2023 |
| Cyrus Harmon | ▼ Sell | Open Market | 5,000 | $30K | 6/5/2023 |
| Shane William Charles Kovacs | ▲ Buy | Open Market | 10,000 | — | 4/6/2023 |
| Sean Bohen | ▲ Buy | Grant | 20,000 | — | 9/21/2022 |
| Shane William Charles Kovacs | ▲ Buy | Open Market | 20,000 | — | 9/2/2022 |
| BVF PARTNERS L P/IL | ▲ Buy | Open Market | 158,583 | $640K | 6/10/2022 |
| BVF PARTNERS L P/IL | ▲ Buy | Open Market | 41,417 | $167K | 6/10/2022 |
| Kinney Horn | ▲ Buy | Option Exercise | 5,253 | $11K | 3/10/2022 |
| Kinney Horn | ▼ Sell | Open Market | 5,253 | $25K | 3/10/2022 |
| Kinney Horn | ▲ Buy | Option Exercise | 5,251 | $11K | 2/10/2022 |
| Kinney Horn | ▼ Sell | Other | 5,251 | — | 2/10/2022 |
| Kinney Horn | ▲ Buy | Option Exercise | 5,251 | $11K | 1/10/2022 |
| Kinney Horn | ▼ Sell | Open Market | 5,251 | $36K | 1/10/2022 |
| Kinney Horn | ▲ Buy | Option Exercise | 5,251 | $11K | 12/10/2021 |
| Kinney Horn | ▼ Sell | Open Market | 5,251 | $55K | 12/10/2021 |
| David C. Myles | ▼ Sell | Open Market | 10,000 | $103K | 12/10/2021 |
| BVF PARTNERS L P/IL | ▲ Buy | Open Market | 362,430 | $3.4M | 11/30/2021 |
| BVF PARTNERS L P/IL | ▲ Buy | Open Market | 341,977 | $3.2M | 11/30/2021 |
| BVF PARTNERS L P/IL | ▲ Buy | Open Market | 35,268 | $331K | 11/30/2021 |
| Cyrus Harmon | ▼ Sell | Open Market | 400 | $10K | 11/29/2021 |
| Kinney Horn | ▲ Buy | Option Exercise | 5,251 | $11K | 11/10/2021 |
| Kinney Horn | ▲ Buy | Option Exercise | 22,417 | $426K | 11/10/2021 |
| Kinney Horn | ▼ Sell | Open Market | 27,668 | $744K | 11/10/2021 |
| Cyrus Harmon | ▼ Sell | Open Market | 7,445 | $207K | 10/19/2021 |
| Cyrus Harmon | ▼ Sell | Open Market | 4,555 | $128K | 10/19/2021 |
| Sean Bohen | ▲ Buy | Option Exercise | 5,000 | $24K | 10/14/2021 |
| Sean Bohen | ▼ Sell | Open Market | 4,649 | $141K | 10/14/2021 |
| Sean Bohen | ▼ Sell | Open Market | 351 | $11K | 10/14/2021 |
| Kinney Horn | ▼ Sell | Open Market | 2,105 | $58K | 10/11/2021 |
| Kinney Horn | ▼ Sell | Open Market | 3,146 | $89K | 10/11/2021 |
| Kinney Horn | ▲ Buy | Option Exercise | 5,251 | $11K | 10/11/2021 |
| Sean Bohen | ▲ Buy | Option Exercise | 1,085 | $5K | 9/27/2021 |
| Sean Bohen | ▼ Sell | Open Market | 1,085 | $33K | 9/27/2021 |
| Cyrus Harmon | ▼ Sell | Open Market | 12,000 | $316K | 9/20/2021 |
| Kinney Horn | ▲ Buy | Option Exercise | 5,251 | $11K | 9/10/2021 |
| Kinney Horn | ▼ Sell | Open Market | 5,251 | $154K | 9/10/2021 |
| Sean Bohen | ▲ Buy | Option Exercise | 2,631 | $13K | 9/8/2021 |
| Sean Bohen | ▼ Sell | Open Market | 2,631 | $79K | 9/8/2021 |
| Sean Bohen | ▲ Buy | Option Exercise | 413 | $2K | 9/7/2021 |
| Sean Bohen | ▼ Sell | Open Market | 413 | $12K | 9/7/2021 |
| Sean Bohen | ▲ Buy | Option Exercise | 871 | $4K | 9/1/2021 |
| Sean Bohen | ▼ Sell | Open Market | 871 | $26K | 9/1/2021 |
| Cyrus Harmon | ▼ Sell | Open Market | 12,000 | $300K | 8/19/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
OLMA Joins 12 Healthcare Stocks Moving in Pre-Market
OLMA was among 12 healthcare stocks that moved in Wednesday's pre‑market session, signaling early interest from traders. The move comes while the stock sits near its 52‑week low and a low RSI of 19.1, suggesting it may be oversold. This early activity could reflect new market sentiment or a reaction to broader healthcare sector dynamics.
OLMA Joins 12 Healthcare Stocks Moving in Pre-Market. OLMA was among 12 healthcare stocks that moved in Wednesday's pre‑market session, signaling early interest from traders. The move comes while the stock sits near its 52‑week low and a low RSI of 19.1, suggesting it may be oversold. This early activity could reflect new market sentiment or a reaction to broader healthcare sector dynamics.